Pharmacokinetic (PK) assessment of revumenib in patients with relapsed/refractory (R/R) acute leukemias harboring a KMT2A rearrangement (KMT2Ar) or NPM1 mutation (NPM1m): Impact of food and concomitant medications.

Poster Presentation | Jun 1, 2026

Author

Cobbina H, et al.

Congress

American Society of Clinical Oncology Annual Meeting

Chicago, Illinois | May 29 – June 2, 2026